Gut reactions: Breaking down xenobiotic–microbiome interactions

Cites (323)

Items 201–320 of 320

1. The Impact of the Gut Microbiota on Drug Metabolism and Clinical Outcome.
   Elaine F. Enright, Cormac G. M. Gahan, Susan A. Joyce, Brendan T. Griffin · 2016 · PubMed Central
2. Exposure to traffic-related air pollution and the composition of the gut microbiota in overweight and obese adolescents
   Alderete, Tanya L., Jones, Roshonda B., Chen, Zhanghua, Kim, Jeniffer S., Habre, Rima, Lurmann, Frederick, Gilliland, Frank D., Goran, Michael I. · 2018 · Environmental Research
3. Regulation of hepatic drug-metabolizing enzymes in germ-free mice by conventionalization and probiotics
   Selwyn, Felcy Pavithra, Cheng, Sunny Lihua, Klaassen, Curtis D, Cui, Julia Yue · 2016 · Drug Metabolism and Disposition
4. Daidzein and Genistein Are Converted to Equol and 5-Hydroxy-Equol by Human Intestinal Slackia isoflavoniconvertens in Gnotobiotic Rats3
   Anastasia Matthies, Gunnar Loh, Michaël Blaut, Annett Braune · 2011 · Journal of Nutrition
5. Adding fuel to the fire: the impact of stress on the ageing brain
   Prenderville, Jack A., Kennedy, Paul J., Dinan, Timothy G., Cryan, John F. · 2015 · Trends in Neurosciences
6. Cardiovascular and antiobesity effects of resveratrol mediated through the gut microbiota
   Bird, Julia K, Raederstorff, Daniel, Weber, Peter, Steinert, Robert E · 2017 · Advances in Nutrition
7. Impact of chronic exposure to low doses of chlorpyrifos on the intestinal microbiota in the Simulator of the Human Intestinal Microbial Ecosystem (SHIME) and in the rat
   Joly, Claire, Gay-Quéheillard, Jérôme, Léké, André, Chardon, Karen, Delanaud, Stéphane, Bach, Véronique, Khorsi-Cauet, Hafida · 2013 · Environmental Science and Pollution Research
8. Pharmacological Targeting of the Host–Pathogen Interaction: Alternatives to Classical Antibiotics to Combat Drug-Resistant Superbugs
   Jason Munguia, Victor Nizet · 2017 · Trends in Pharmacological Sciences
9. Precision medicine using microbiota
   Jobin, Christian · 2018 · Science
10. Human intestinal gas measurement systems: in vitro fermentation and gas capsules
    Jian Zhen Ou, Chu K Yao, Asaf Rotbart, Jane G. Muir, Peter R. Gibson, Kourosh Kalantar‐Zadeh · 2015 · Trends in biotechnology
11. URINARY EXCRETION OF CHOLINE METABOLITES FOLLOWING CHOLINE ADMINISTRATION IN NORMALS AND PATIENTS WITH HEPATOBILIARY DISEASES 1
    de la Huerga, Jesus, Popper, Hans · 1951 · Journal of Clinical Investigation
12. Prebiotic attenuation of olanzapine-induced weight gain in rats: analysis of central and peripheral biomarkers and gut microbiota
    Kao, Amy Chia-Ching, Spitzer, Sonia, Anthony, Daniel C., Lennox, Belinda, Burnet, Philip W. J. · 2018 · Translational Psychiatry
13. Modeling metabolism of the human gut microbiome
    Magnúsdóttir, Stefanía, Thiele, Ines · 2018 · Current Opinion in Biotechnology
14. Gut microbiome as a clinical tool in gastrointestinal disease management: are we there yet?
    Quigley, Eamonn M. M. · 2017 · Nature Reviews Gastroenterology & Hepatology
15. The structures of the colonic mucosa-associated and luminal microbial communities are distinct and differentially affected by a prolonged murine stressor
    Jeffrey D. Galley, Zhongtang Yu, Purnima Kumar, Scot E. Dowd, Mark Lyte, Michael T. Bailey · 2014 · Gut Microbes
16. Timing the day: what makes bacterial clocks tick?
    Johnson, Carl Hirschie, Zhao, Chi, Xu, Yao, Mori, Tetsuya · 2017 · Nature Reviews Microbiology
17. RNA-Seq Quantification of Hepatic Drug Processing Genes in Germ-Free Mice
    Selwyn, Felcy Pavithra, Cui, Julia Yue, Klaassen, Curtis D. · 2015 · Drug Metabolism and Disposition
18. Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil
    Nakayama, Haruyuki, Kinouchi, Takemi, Kataoka, Keiko, Akimoto, Shigeru, Matsuda, Yoshiko, Ohnishi, Yoshinari · 1997 · Pharmacogenetics
19. Effects of orally administered antibiotics on the bioavailability of amlodipine
    Hye Hyun Yoo, In Sook Kim, Dae-Hyeong Yoo, Dong‐Hyun Kim · 2015 · Journal of Hypertension
20. Targeted treatment for bacterial infections: prospects for pathogen-specific antibiotics coupled with rapid diagnostics
    Tucker Maxson, Douglas A. Mitchell · 2015 · Tetrahedron
21. Xenobiotics: Interaction with the Intestinal Microflora
    Kun Lü, Ridwan Mahbub, James G. Fox · 2015 · ILAR Journal
22. Role of gut microbiota in aging-related health decline: insights from invertebrate models
    Rebecca I. Clark, David W. Walker · 2017 · Cellular and Molecular Life Sciences
23. Gut Microbiota Analysis in Rats with Methamphetamine-Induced Conditioned Place Preference
    Tingting Ning, Xiaokang Gong, Lingling Xie, Baomiao Ma · 2017 · Frontiers in Microbiology
24. Microbial-Host Co-metabolites Are Prodromal Markers Predicting Phenotypic Heterogeneity in Behavior, Obesity, and Impaired Glucose Tolerance
    Dumas, Marc-Emmanuel, Rothwell, Alice R., Hoyles, Lesley, Aranias, Thomas, Chilloux, Julien, Calderari, Sophie, Noll, Elisa M., Péan, Noémie, Boulangé, Claire L., Blancher, Christine et al. · 2017 · Cell Reports
25. Effects of gut microbiota on the microRNA and mRNA expression in the hippocampus of mice
    Chen, Jian-jun, Zeng, Ben-hua, Li, Wen-wen, Zhou, Chan-juan, Fan, Song-hua, Cheng, Ke, Zeng, Li, Zheng, Peng, Fang, Liang, Wei, Hong et al. · 2017 · Behavioural Brain Research
26. The analysis of para-cresol production and tolerance in Clostridium difficile 027 and 012 strains
    Lisa F. Dawson, Elizabeth H. Donahue, Stephen T. Cartman, Richard H. Barton, Jake G. Bundy, Ruth McNerney, Nigel Peter Minton, Brendan W. Wren · 2011 · BMC Microbiology
27. Symposium Article: Molecular and Physical Mechanisms of First-Pass Extraction
    Hall, Stephen D., Thummel, Kenneth E., Watkins, Paul B., Lown, Kenneth S., Benet, Leslie Z., Paine, Mary F., Mayo, Robert R., Turgeon, D. Kim, Bailey, David G., Fontana, Robert J. et al. · 1999 · Drug Metabolism and Disposition
28. The Gut Microbiome as Therapeutic Target in Central Nervous System Diseases: Implications for Stroke
    Winek, Katarzyna, Dirnagl, Ulrich, Meisel, Andreas · 2016 · Neurotherapeutics
29. Finding the needle in the haystack: systematic identification of psychobiotics
    Aisling Bambury, Kiran Sandhu, John F. Cryan, Timothy G. Dinan · 2017 · British Journal of Pharmacology
30. Glyphosate: too much of a good thing?
    Cuhra, Marek, Bøhn, Thomas, Cuhra, Petr · 2016 · Frontiers in Environmental Science
31. Molecular aspects of circadian pharmacology and relevance for cancer chronotherapy
    Ozturk, Narin, Ozturk, Dilek, Kavakli, Ibrahim Halil, Okyar, Alper · 2017 · International Journal of Molecular Sciences
32. Bacterial Diversity of Intestinal Microbiota in Patients with Substance Use Disorders Revealed by 16S rRNA Gene Deep Sequencing
    Yu Xu, Zhenrong Xie, Huawei Wang, Zongwen Shen, Youbing Guo, Yunhong Gao, Xin Chen, Qiang Wu, Xuejun Li, Kunhua Wang · 2017 · Scientific Reports
33. Intestinal flora induces the expression of Cyp3a in the mouse liver
    Tsuguto Toda, Noriyuki Saito, Nobutomo Ikarashi, Kiyomi Ito, Masaaki Yamamoto, Atsusi ISHIGE, Kazuhide Watanabe, Kiyoshi Sugiyama · 2009 · Xenobiotica
34. -Glucuronidase in human intestinal microbiota is necessary for the colonic genotoxicity of the food-borne carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline in rats
    Humblot, C., Murkovic, M., Rigottier-Gois, L., Bensaada, M., Bouclet, A., Andrieux, C., Anba, J., Rabot, S. · 2007 · Carcinogenesis
35. Designer Probiotics: Paving the Way to Living Therapeutics
    Birbal Singh, Gorakh Mal, Francesco Marotta · 2017 · Trends in biotechnology
36. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus
    Muhammad Umar Sohail, Asmaa A. Al Thani, Haseeb Anwar, Roberto Rizzi, Hany E. S. Marei · 2017 · Journal of Diabetes Research
37. Transformation of the Anticancer Drug Doxorubicin in the Human Gut Microbiome
    Austin Yan, Elizabeth J. Culp, Julie Ann Perry, Jennifer T. Lau, Lesley T. MacNeil, Michael Gordon Surette, Gerard D. Wright · 2017 · ACS Infectious Diseases
38. Substantial decreases in the number and diversity of microbiota during chemotherapy-induced gastrointestinal mucositis in a rat model
    Fijlstra, Margot, Ferdous, Mithila, Koning, Anne M., Rings, Edmond H. H. M., Harmsen, Hermie J. M., Tissing, Wim J. E. · 2015 · Supportive Care in Cancer
39. Microbiome and metabolome modifying effects of several cardiovascular disease interventions in apo-E-/- mice
    Ryan, Paul M., London, Lis E. E., Bjorndahl, Trent C., Mandal, Rupasri, Murphy, Kiera, Fitzgerald, Gerald F., Shanahan, Fergus, Ross, R. Paul, Wishart, David S., Caplice, Noel M. et al. · 2017 · Microbiome
40. Impact of Gut Microbiota on Intestinal and Hepatic Levels of Phase 2 Xenobiotic-Metabolizing Enzymes in the Rat
    Walter Meinl, Silke Sczesny, Regina Brigelius‐Flohé, Michaël Blaut, Hansruedi R. Glatt · 2009 · Drug Metabolism and Disposition
41. Exercise is a Novel Promoter of Intestinal Health and Microbial Diversity
    Sara C. Campbell, Paul J. Wisniewski · 2016 · Exercise and Sport Sciences Reviews
42. Developmental Regulation of Drug-Processing Genes in Livers of Germ-Free Mice
    Felcy Pavithra Selwyn, Sunny Lihua Cheng, Theo K. Bammler, Bhagwat Prasad, Marc Vrana, Curtis D. Klaassen, Julia Yue Cui · 2015 · Toxicological Sciences
43. CONTRIBUTIONS OF HOST AND INTESTINAL MICROFLORA IN THE METABOLISM OF l-DOPA BY THE RAT
    Barry R. Goldin, Mark A. Peppercorn, Peter Goldman · 1973 · Journal of Pharmacology and Experimental Therapeutics
44. Gastrointestinal Organoids: Understanding the Molecular Basis of the Host–Microbe Interface
    David R. Hill, Jason R. Spence · 2016 · Cellular and Molecular Gastroenterology and Hepatology
45. The influence of the host on expression of intestinal microbial enzyme activities involved in metabolism of foreign compounds
    Christopher B. Cole, R. Fuller, Adrien Mallet, Ian R. Rowland · 1985 · Journal of Applied Bacteriology
46. Prediction of drug–drug interaction potential using physiologically based pharmacokinetic modeling
    Jee Sun Min, Soo Kyung Bae · 2017 · Archives of Pharmacal Research
47. The Gut Microbiota in Inflammatory Bowel Disease
    Donal Sheehan, Fergus Shanahan · 2017 · Gastroenterology Clinics of North America
48. Gut-Brain Axis and Behavior
    Clair R. Martin, Emeran A. Mayer · 2017 · Nestlé Nutrition Institute Workshop series
49. Synthesis of conjugated linoleic acid by the linoleate isomerase complex in food-derived lactobacilli
    Bo Kyung Yang, Haiqin Chen, Zhennan Gu, Fengwei Tian, R. Paul Ross, Catherine Stanton, Yong Q. Chen, Wei Chen, Haihua Zhang · 2014 · Journal of Applied Microbiology
50. Evidence of a DHA Signature in the Lipidome and Metabolome of Human Hepatocytes
    Veronica Ghini, Mattia Di Nunzio, Leonardo Tenori, Veronica Valli, Francesca Danesi, Francesco Capozzi, Claudio Luchinat, Alessandra Bordoni · 2017 · International Journal of Molecular Sciences
51. Isolation and characterization of the equol-producing bacterium Slackia sp. strain NATTS
    Hirokazu Tsuji, Kaoru Moriyama, Koji Nomoto, Naoto Miyanaga, Hideyuki Akaza · 2010 · Archives of Microbiology
52. Xenobiotic Metabolism and Gut Microbiomes
    Anubhav Das, Meenakshi Srinivasan, Tarini Shankar Ghosh, Sharmila S. Mande · 2016 · PLoS ONE
53. In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?
    Michael Niehues, Andreas Hensel · 2009 · Journal of Pharmacy and Pharmacology
54. Integrating ecological and engineering concepts of resilience in microbial communities
    Song, Hyun-Seob, Renslow, Ryan S., Fredrickson, Jim K., Lindemann, Stephen R. · 2015 · Frontiers in Microbiology
55. Genome Mining for Radical SAM Protein Determinants Reveals Multiple Sactibiotic-Like Gene Clusters
    Kiera Murphy, Órla O’Sullivan, Mary C. Rea, Paul D. Cotter, R. Paul Ross, Colin Hill · 2011 · PLoS ONE
56. Microbial trimethylamine- N -oxide as a disease marker: something fishy?
    Bjarne Landfald, Jørgen Valeur, Arnold Berstad, Jan Raa · 2017 · Microbial Ecology in Health and Disease
57. Metagenomic data-mining reveals contrasting microbial populations responsible for trimethylamine formation in human gut and marine ecosystems
    Eleanor Jameson, Andrew C. Doxey, Ruth L. Airs, Kevin J. Purdy, John Colin Murrell, Yin Chen · 2016 · Microbial Genomics
58. N-3 Polyunsaturated Fatty Acids through the Lifespan: Implication for Psychopathology
    Pusceddu, Matteo M., Kelly, Philip, Stanton, Catherine, Cryan, John F., Dinan, Timothy G. · 2016 · International Journal of Neuropsychopharmacology
59. Involvement of the intestinal microflora in nitrazepam‐induced teratogenicity in rats and its relationship to nitroreduction
    Satoshi Takeno, Takeshi Sakai · 1991 · Teratology
60. Antioxidant activities of aqueous extracts from 12 Chinese edible flowers in vitro and in vivo
    Feng Wang, Miao Miao, Hui Xia, Ligang Yang, Shaokang Wang, Guiju Sun · 2016 · Food & Nutrition Research
61. Adverse Health Events Related to Self-Medication Practices Among Elderly: A Systematic Review
    Médéa Locquet, Germain Honvo, Véronique Rabenda, Thierry J. Van Hees, Jean Pétermans, Jean‐Yves Reginster, Olivier Bruyère · 2017 · Drugs & Aging
62. Emulating Host-Microbiome Ecosystem of Human Gastrointestinal Tract in Vitro
    Gun-Seok Park, Min Hee Park, Woojung Shin, Connie Zhao, Sameer Sheikh, So Jung Oh, Hyun Jung Kim · 2017 · Stem Cell Reviews and Reports
63. Microbial regulation of hippocampal miRNA expression: implications for transcription of kynurenine pathway enzymes
    Moloney, Gerard M., O’Leary, Olivia F., Salvo-Romero, Eloisa, Desbonnet, Lieve, Shanahan, Fergus, Dinan, Timothy G., Clarke, Gerard, Cryan, John F. · 2017 · Behavioural Brain Research
64. Caffeic Acid Metabolism by Gnotobiotic Rats and Their Intestinal Bacteria
    Mark A. Peppercorn, Peter Goldman · 1972 · Proceedings of the National Academy of Sciences
65. All Roads Lead to the miRNome: miRNAs Have a Central Role in the Molecular Pathophysiology of Psychiatric Disorders
    Richard M. O’Connor, Anand Gururajan, Timothy G. Dinan, Paul J. Kenny, John F. Cryan · 2016 · Trends in Pharmacological Sciences
66. Microbial Determinants of Biochemical Individuality and Their Impact on Toxicology and Pharmacology
    Andrew D. Patterson, Peter James Turnbaugh · 2014 · Cell Metabolism
67. Phase II Conjugates of Urolithins Isolated from Human Urine and Potential Role of β-Glucuronidases in Their Disposition
    Jakub P. Piwowarski, Iwona J. Stanisławska, Sebastian Granica, Joanna Stefańska, Anna Karolina Kiss · 2017 · Drug Metabolism and Disposition
68. Faecal microRNAs: indicators of imbalance at the host-microbe interface?
    Moloney, G.M., Viola, M.F., Hoban, A.E., Dinan, T.G., Cryan, J.F. · 2018 · Beneficial Microbes
69. Role of the intestinal microflora in clonazepam metabolism in the rat
    Gary W. Elmer, Rory P. Remmel · 1984 · Xenobiotica
70. Cloning and characterization of upp, a gene encoding uracil phosphoribosyltransferase from Lactococcus lactis
    Jan Martinussen, Karin Hammer · 1994 · Journal of Bacteriology
71. Pharmacokinetic drug interactions of antimicrobial drugs: a systematic review on oxazolidinones, rifamycines, macrolides, fluoroquinolones, and Beta-lactams
    Bolhuis, Mathieu S., Panday, Prashant N., Pranger, Arianna D., Kosterink, Jos G. W., Alffenaar, Jan-Willem C. · 2011 · Pharmaceutics
72. Effect of Probiotics on Pharmacokinetics of Orally Administered Acetaminophen in Mice
    Jeon-Kyung Kim, Min Sun Choi, Jin-Ju Jeong, Su-Min Lim, In Sook Kim, Hye Hyun Yoo, Dong‐Hyun Kim · 2017 · Drug Metabolism and Disposition
73. Tyrosine decarboxylase from Lactobacillus brevis: Soluble expression and characterization
    Kai Zhang, Ye Ni · 2013 · Protein Expression and Purification
74. Carnitine and choline derivatives containing a trimethylamine group prevent ammonia toxicity in mice and glutamate toxicity in primary cultures of neurons
    Miñana, M D, Hermenegildo, C, Llsansola, M, Montoliu, C, Grisolía, S, Felipo, V · 1996 · The Journal of Pharmacology and Experimental Therapeutics
75. First bacterial chalcone isomerase isolated from Eubacterium ramulus
    Claudia Herles, Annett Braune, Michaël Blaut · 2004 · Archives of Microbiology
76. Drug metabolism in microorganisms
    Cormac D. Murphy · 2014 · Biotechnology Letters
77. Insights on the human microbiome and its xenobiotic metabolism: what is known about its effects on human physiology?
    Tewes Tralau, Juliane Sowada, Andreas Luch · 2014 · Expert Opinion on Drug Metabolism & Toxicology
78. The Biochemistry of Drug Metabolism – An Introduction
    Stefanie D. Krämer, Bernard Testa · 2008 · Chemistry & Biodiversity
79. In-vitro interaction of L-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability?
    Michael Niehues, Andreas Hensel · 2009 · Journal of Pharmacy and Pharmacology
80. Ciprofloxacin Suppresses Cyp3a in Mouse Liver by Reducing Lithocholic Acid-producing Intestinal Flora
    Takahiro Toda, Kanna Ohi, Toshiyuki Kudo, Tomoyuki Yoshida, Nobutomo Ikarashi, Kiyomi Ito, Kiyoshi Sugiyama · 2009 · Drug Metabolism and Pharmacokinetics
81. Blood Trimethylamine-N-Oxide Originates from Microbiota Mediated Breakdown of Phosphatidylcholine and Absorption from Small Intestine
    Wolfgang Stremmel, Kathrin V. Schmidt, Vera Schuhmann, Frank Kratzer, Sven F. Garbade, Claus‐Dieter Langhans, Gert Fricker, Jürgen G. Okun · 2017 · PLoS ONE
82. Thinking small: towards microRNA-based therapeutics for anxiety disorders
    Scott, Karen A, Hoban, Alan E, Clarke, Gerard, Moloney, Gerard M, Dinan, Timothy G, Cryan, John F · 2015 · Expert Opinion on Investigational Drugs
83. Gnotobiotics
    Williams, Sarah C. P. · 2014 · Proceedings of the National Academy of Sciences
84. Deficiency of essential dietary n-3 PUFA disrupts the caecal microbiome and metabolome in mice
    R. Robertson, Clara Seira Oriach, K. Murphy, G. Moloney, J. Cryan, T. Dinan, R. Ross, C. Stanton · 2017 · British Journal of Nutrition
85. Declining public health burden of digoxin toxicity from 1991 to 2004
    Haynes, K, Heitjan, DF, Kanetsky, PA, Hennessy, S · 2008 · Clinical Pharmacology & Therapeutics
86. Quantitative systems pharmacology and the personalized drug–microbiota–diet axis
    Ines Thiele, Catherine M. Clancy, Almut Heinken, Ronan M. T. Fleming · 2017 · Current Opinion in Systems Biology
87. Phages of life – the path to pharma
    Amanda Forde, Colin Hill · 2017 · British Journal of Pharmacology
88. Bacterial acetylation of 5-aminosalicylic acid in faecal suspensions cultured under aerobic and anaerobic conditions
    van Hogezand, R. A., Kennis, H. M., van Schaik, A., Koopman, J. P., van Hees, P. A. M., van Tongeren, J. H. M. · 1992 · European Journal of Clinical Pharmacology
89. The commensal microbiota exacerbate infectious colitis in stressor-exposed mice
    Jeffrey D. Galley, Nicola M. Parry, Brian M. M. Ahmer, James G. Fox, Michael T. Bailey · 2016 · Brain Behavior and Immunity
90. Sustained-Release, Extended-Release, and Other Time-Release Formulations in Neuropsychiatry
    Chittaranjan Andrade · 2015 · The Journal of Clinical Psychiatry
91. Living therapeutics: Scientists genetically modify bacteria to deliver drugs
    Amy Maxmen · 2017 · Nature Medicine
92. Patterns of psychotropic prescribing and polypharmacy in older hospitalized patients in Ireland: the influence of dementia on prescribing
    Kieran Anthony Walsh, Niamh O’Regan, Stephen Byrne, John Patrick Browne, David James Meagher, Suzanne Timmons · 2016 · International Psychogeriatrics
93. Protection against acute hyperammonemia: the role of quaternary amines
    Kloiber, Otmar, Banjac, Borislav, Drewes, Lester R. · 1988 · Toxicology
94. On the Search to Elucidate the Role of Microbiota in the Genesis of Cancer: The Cases of Gastrointestinal and Cervical Cancer
    Francisco Avilés‐Jiménez, Guoqin Yu, Kirvis Torres-Poveda, Vicente Madrid‐Marina, Javier Torres · 2017 · Archives of Medical Research
95. The Biochemistry of Drug Metabolism – An Introduction
    Stefanie D. Krämer, Bernard Testa · 2009 · Chemistry & Biodiversity
96. The pyruvate formate lyase family: sequences, structures and activation
    L. Lehtiö, Adrian Goldman · 2004 · Protein Engineering Design and Selection
97. Fish oil and depression: The skinny on fats
    Mansoor D. Burhani, Mark M. Rasenick · 2017 · Journal of Integrative Neuroscience
98. Psychophysiological stress: a significant parameter in drug pharmacokinetics
    Konstandi, Maria · 2013 · Expert Opinion on Drug Metabolism & Toxicology
99. Latitude as a co‐driver of human gut microbial diversity?
    Emma Dikongué, Laure Ségurel · 2017 · BioEssays
100. Functional food addressing heart health: do we have to target the gut microbiota?
     Ryan, Paul M., Ross, Reynolds Paul, Fitzgerald, Gerald F., Caplice, Noel M., Stanton, Catherine · 2015 · Current Opinion in Clinical Nutrition and Metabolic Care
101. Computational tools for modeling xenometabolism of the human gut microbiota
     Martina Klünemann, Melanie Schmid, Kiran Raosaheb Patil · 2014 · Trends in biotechnology
102. Colonization by non-pathogenic bacteria alters mRNA expression of cytochromes P450 in originally germ-free mice
     Jourová, L., Anzenbacher, P., Lišková, B., Matušková, Z., Hermanová, P., Hudcovic, T., Kozáková, H., Hrnčířová, L., Anzenbacherová, E. · 2017 · Folia Microbiologica
103. Novel metabolites of warfarin produced byBeauveria bassianaandStreptomyces rimosus: a novel application of hplc- nmr
     Richard J. P. Cannell, Tahira Rashid, I. M. Ismail, Philip J. Sidebottom, Andrew R. Knaggs, Peter S. Marshall · 1997 · Xenobiotica
104. The effects of antimicrobial agents upon choline degradation in the intestinal tract
     De La Huerga, J., György, Paul, Waldstein, Sheldon, Katz, Ricardo, Popper, Hans · 1953 · Journal of Clinical Investigation
105. Decarboxylation of orally administered l-dopa in the human digestive tract
     Jan Bergmark, Arvid Carlsson, Ann‐Kathrine Granérus, RUDOLF JAGENBURG, Tor Magnusson, Alvar Svanborg · 1972 · Naunyn-Schmiedeberg s Archives of Pharmacology
106. Mechanism-Based Inactivation of Human Dihydropyrimidine Dehydrogenase by (E)-5-(2-Bromovinyl)uracil in the Presence of NADPH
     Takahito Nishiyama, Kenichiro Ogura, Haruhiro Okuda, Kazuma Suda, Atsushi Kato, Tadashi Watabe · 2000 · Molecular Pharmacology
107. The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications
     Tewes Tralau, Andreas Luch · 2013 · Expert Opinion on Drug Metabolism & Toxicology
108. Microbial transformations of warfarin: stereoselective reduction by Nocardia corallina and Arthrobacter species
     Patrick J. Davis, Jinee D. Rizzo · 1982 · Applied and Environmental Microbiology
109. Microbial models of mammalian metabolism: uses and misuses (clarification of some misconceptions)
     Serge G. Jezequel · 1998 · Journal of Molecular Catalysis B Enzymatic
110. Bacterial production of hydroxylated and amidated metabolites of flurbiprofen
     Tara V. Bright, Benjamin R. Clark, Eimear M. O'Brien, Cormac D. Murphy · 2011 · Journal of Molecular Catalysis B Enzymatic
111. Development of fecal microbial enzyme mix for mutagenicity assay of natural products
     Yeo, Hee Kyung · 2012 · Journal of Microbiology and Biotechnology
112. A Little O2 May Go a Long Way in Structuring the GI Microbiome
     Thomas Mitchell Schmidt, John Y. Kao · 2014 · Gastroenterology
113. Digoxin: time to take the gloves off?
     Eade, Emma, Cooper, Rebecca, Mitchell, Andrew R.J. · 2013 · International Journal of Cardiology
114. Degradation of bromazepam by the intestinal microflora.
     Junko Fujii, Nobuo Inotsume, Masahiro Nakano · 1987 · Chemical and Pharmaceutical Bulletin
115. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage
     I. Pieper, M. Bertau · 2010 · Expert Opinion on Drug Metabolism & Toxicology
116. Application of a physiologically‐based pharmacokinetic model for the prediction of bumetanide plasma and brain concentrations in the neonate
     Maria D. Donovan, Khaled Abduljalil, John F. Cryan, Geraldine B. Boylan, Brendan T. Griffin · 2018 · Biopharmaceutics & Drug Disposition
117. Stress matters: a double-blind, randomized controlled trial on the effects of a multispecies probiotic on neurocognition
     Silvia Papalini, Franziska Michels, Nils Kohn, Joost Wegman, van Hemert S., Karin Roelofs A, Alejandro Arias Vásquez, Esther Aarts · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
118. Survey of pharmacists and physicians on drug interactions between combined oral contraceptives and broad-spectrum antibiotics
     Kelly P. Masters, Carr BM · 2009 · Pharmacy Practice
119. Biologic stress, oxidative stress, and resistance to drugs: what is hidden behind
     Pantelidou, Maria, Tsiakitzis, Karyofyllis, Rekka, Eleni, Kourounakis, Panos · 2017 · Molecules
120. Are Gut Microbes Responsible for Post-dieting Weight Rebound?
     Julien Chilloux, Marc‐Emmanuel Dumas · 2017 · Cell Metabolism